Zu "1239908-20-3" wurden 2 Artikel gefunden!
Für die Filterung wurden keine Ergebnisse gefunden!
Ixazomib citrate
Artikelnummer: TGM-T8397-10mg
Description: Ixazomib citrate (MLN9708) is a prodrug of Ixazomib (MLN-2238) and an orally bioavailable second-generation proteasome inhibitor with an IC50 of 3.4 nM, exhibiting potential antineoplastic activity. Target: Proteasome, Autophagy. Smiles:...
| Schlagworte: | MLN9708 |
| Anwendung: | Targets 20S proteasome subunit beta 5 [EC:3.4.25.1] (PSMB5) |
| CAS | 1239908-20-3 |
| MW: | 517.12 D |
ab 43,00 €
![Ixazomib citrate [MLN9708]](https://www.biomol.com/media/image/4e/c4/fc/AG-CR1-3671-M001_200x200.png "Ixazomib citrate [MLN9708]")
Ixazomib citrate [MLN9708]
Artikelnummer: AG-CR1-3671-M001
Synthetic. Chemical. CAS: 1239908-20-3. Formula: C20H23BCl2N2O9. MW: 517.1. Synthetic. Potent selective and reversible proteasome inhibitor (all proteolytic subunits). Targets the chymotrypsin-like beta5 subunit of the constitutive 20S proteasome (IC50=3.4nM). Cross-reacts and inhibits the trypsin-like beta2 subunit...
| Schlagworte: | (R)-2,2'-(2-(1-(2-(2,5-Dichlorobenzamido)acetamido)-3-methylbutyl)-5-oxo-1,3,2-dioxaborolane-4,4-diyl)diacetic acid |
| Anwendung: | Proteasome inhibitor |
| CAS | 1239908-20-3 |
| MW: | 517,1 D |
ab 39,00 €
